Medicine
Aklief 50 mcg/g cream
Aklief 50 mcg/g cream is a prescription medicine containing Trifarotene for topical use, marketed by Galderma Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20˚ to 25˚C (68˚ to 77˚F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Trifarotene
- Brand
- Aklief
- Strength
- 50 mcg/g
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Galderma Laboratories
- Manufacturer
- Galderma Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20˚ to 25˚C (68˚ to 77˚F), excursions permitted to 15° to 30°C (59° to 86°F). - Keep away from heat. - Keep out of reach of children.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AD06 Trifarotene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 October 2019
- Identifiers
- RxCUI 2205642, 2205647DailyMed set ID 62d910db-85a6-4696-b69b-4bd2f3080cfcNDC 0299-5935Application NDA211527
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 45 g in 1 bottle, pump | 0299-5935-45 | Galderma Laboratories | 4 October 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 October 2019 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Trifarotene is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. It is available as cream for topical use. MedsAcross supplies Trifarotene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TrifaroteneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AKLIEF prescribing information (Galderma Laboratories) · U.S. National Library of Medicine, DailyMed
Need Aklief 50 mcg/g cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.